Annual Total Liabilities
$1.21 B
+$87.96 M+7.84%
31 December 2023
Summary:
Cytokinetics Incorporated annual total liabilities is currently $1.21 billion, with the most recent change of +$87.96 million (+7.84%) on 31 December 2023. During the last 3 years, it has risen by +$790.22 million (+187.96%). CYTK annual total liabilities is now at all-time high.CYTK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$1.45 B
+$34.73 M+2.45%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly total liabilities is currently $1.45 billion, with the most recent change of +$34.73 million (+2.45%) on 30 September 2024. Over the past year, it has increased by +$270.56 million (+22.94%). CYTK quarterly total liabilities is now at all-time high.CYTK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.8% | +22.9% |
| 3 y3 years | +188.0% | +150.6% |
| 5 y5 years | +553.5% | +599.6% |
CYTK Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +188.0% | at high | +150.6% |
| 5 y | 5 years | at high | +553.5% | at high | +599.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Cytokinetics Incorporated Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.45 B(+2.5%) |
| June 2024 | - | $1.42 B(+17.5%) |
| Mar 2024 | - | $1.20 B(-0.5%) |
| Dec 2023 | $1.21 B(+7.8%) | $1.21 B(+2.6%) |
| Sept 2023 | - | $1.18 B(+6.0%) |
| June 2023 | - | $1.11 B(-0.5%) |
| Mar 2023 | - | $1.12 B(-0.3%) |
| Dec 2022 | $1.12 B(+87.9%) | $1.12 B(+2.8%) |
| Sept 2022 | - | $1.09 B(+65.4%) |
| June 2022 | - | $660.30 M(-10.8%) |
| Mar 2022 | - | $739.99 M(+23.9%) |
| Dec 2021 | $597.46 M(+42.1%) | $597.46 M(+3.3%) |
| Sept 2021 | - | $578.52 M(+5.6%) |
| June 2021 | - | $547.81 M(+7.6%) |
| Mar 2021 | - | $509.22 M(+21.1%) |
| Dec 2020 | $420.42 M(+39.8%) | $420.42 M(+29.6%) |
| Sept 2020 | - | $324.51 M(+4.5%) |
| June 2020 | - | $310.57 M(+2.7%) |
| Mar 2020 | - | $302.29 M(+0.5%) |
| Dec 2019 | $300.75 M(+62.4%) | $300.75 M(+45.1%) |
| Sept 2019 | - | $207.26 M(+2.0%) |
| June 2019 | - | $203.11 M(+4.0%) |
| Mar 2019 | - | $195.24 M(+5.4%) |
| Dec 2018 | $185.24 M(+0.1%) | $185.24 M(+3.9%) |
| Sept 2018 | - | $178.21 M(+3.6%) |
| June 2018 | - | $172.07 M(-4.6%) |
| Mar 2018 | - | $180.33 M(-2.5%) |
| Dec 2017 | $184.97 M(+144.1%) | $184.97 M(+3.2%) |
| Sept 2017 | - | $179.28 M(+8.2%) |
| June 2017 | - | $165.63 M(-2.6%) |
| Mar 2017 | - | $169.99 M(+124.3%) |
| Dec 2016 | $75.78 M(+62.5%) | $75.78 M(+1.1%) |
| Sept 2016 | - | $74.92 M(+30.5%) |
| June 2016 | - | $57.41 M(+3.8%) |
| Mar 2016 | - | $55.31 M(+18.6%) |
| Dec 2015 | $46.65 M(+14.0%) | $46.65 M(+33.7%) |
| Sept 2015 | - | $34.90 M(-7.8%) |
| June 2015 | - | $37.84 M(-0.6%) |
| Mar 2015 | - | $38.06 M(-6.9%) |
| Dec 2014 | $40.90 M(+42.3%) | $40.90 M(+201.8%) |
| Sept 2014 | - | $13.55 M(-22.3%) |
| June 2014 | - | $17.45 M(-17.3%) |
| Mar 2014 | - | $21.10 M(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $28.75 M(+285.0%) | $28.75 M(-40.4%) |
| Sept 2013 | - | $48.26 M(+13.4%) |
| June 2013 | - | $42.57 M(+580.0%) |
| Mar 2013 | - | $6.26 M(-16.2%) |
| Dec 2012 | $7.47 M(+62.5%) | $7.47 M(+57.4%) |
| Sept 2012 | - | $4.74 M(+15.7%) |
| June 2012 | - | $4.10 M(-9.4%) |
| Mar 2012 | - | $4.52 M(-1.5%) |
| Dec 2011 | $4.59 M(-38.5%) | $4.59 M(-8.7%) |
| Sept 2011 | - | $5.03 M(-8.6%) |
| June 2011 | - | $5.50 M(-9.4%) |
| Mar 2011 | - | $6.08 M(-18.7%) |
| Dec 2010 | $7.48 M(-64.7%) | $7.48 M(+10.0%) |
| Sept 2010 | - | $6.80 M(-7.7%) |
| June 2010 | - | $7.36 M(-59.7%) |
| Mar 2010 | - | $18.26 M(-13.8%) |
| Dec 2009 | $21.17 M(-43.8%) | $21.17 M(-2.9%) |
| Sept 2009 | - | $21.81 M(-12.8%) |
| June 2009 | - | $25.00 M(-45.3%) |
| Mar 2009 | - | $45.73 M(+21.3%) |
| Dec 2008 | $37.69 M(-32.0%) | $37.69 M(-11.8%) |
| Sept 2008 | - | $42.74 M(-8.6%) |
| June 2008 | - | $46.78 M(-9.5%) |
| Mar 2008 | - | $51.71 M(-6.7%) |
| Dec 2007 | $55.45 M(-12.3%) | $55.45 M(-6.3%) |
| Sept 2007 | - | $59.20 M(-3.7%) |
| June 2007 | - | $61.48 M(-5.5%) |
| Mar 2007 | - | $65.05 M(+2.9%) |
| Dec 2006 | $63.20 M(+253.1%) | $63.20 M(+231.6%) |
| Sept 2006 | - | $19.06 M(+13.5%) |
| June 2006 | - | $16.79 M(+7.5%) |
| Mar 2006 | - | $15.62 M(-12.7%) |
| Dec 2005 | $17.90 M(-12.9%) | $17.90 M(+1.3%) |
| Sept 2005 | - | $17.68 M(+1.9%) |
| June 2005 | - | $17.34 M(-14.5%) |
| Mar 2005 | - | $20.29 M(-1.3%) |
| Dec 2004 | $20.55 M(-86.7%) | $20.55 M(-0.0%) |
| Sept 2004 | - | $20.55 M(-4.3%) |
| June 2004 | - | $21.48 M(-86.0%) |
| Mar 2004 | - | $153.50 M(-0.9%) |
| Dec 2003 | $154.90 M(+32.7%) | $154.90 M |
| Dec 2002 | $116.76 M(+0.3%) | - |
| Dec 2001 | $116.37 M(+40.4%) | - |
| Dec 2000 | $82.86 M | - |
FAQ
- What is Cytokinetics Incorporated annual total liabilities?
- What is the all time high annual total liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual total liabilities year-on-year change?
- What is Cytokinetics Incorporated quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly total liabilities year-on-year change?
What is Cytokinetics Incorporated annual total liabilities?
The current annual total liabilities of CYTK is $1.21 B
What is the all time high annual total liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual total liabilities is $1.21 B
What is Cytokinetics Incorporated annual total liabilities year-on-year change?
Over the past year, CYTK annual total liabilities has changed by +$87.96 M (+7.84%)
What is Cytokinetics Incorporated quarterly total liabilities?
The current quarterly total liabilities of CYTK is $1.45 B
What is the all time high quarterly total liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly total liabilities is $1.45 B
What is Cytokinetics Incorporated quarterly total liabilities year-on-year change?
Over the past year, CYTK quarterly total liabilities has changed by +$270.56 M (+22.94%)